6 pharmaceutical enterprise projects are selected into the Ministry of Industry and Information Technology's 2021 new generation information technology and manufacturing integrated development pilot demonstration list

 On September 27, the Ministry of Industry and Information Technology released a list of pilot demonstrations for the development of a new generation of information technology and manufacturing integration in 2021.
Among them, there are 82 "directions for the implementation of the integration of two industrialization management systems" and "specialized professional industrial Internet platform directions".
There are 69, 31 "directions for improving industrial information security capabilities", and 12 "directions for Sino-German smart manufacturing cooperation"
.
According to the list of "Information and Industrialization Integration Management System Implementation Directions", 6 enterprise projects in the pharmaceutical field were selected, including Sichuan New Green Pharmaceutical Technology Development Co.
, Ltd.
"Traditional Chinese Medicine Formula Granule Production Quality Traceability Project", Zhuzhou Qianjin Pharmaceutical Co.
, Ltd.
Co.
, Ltd.
"proprietary precision marketing capabilities" and so on
.
These 6 companies will be introduced in detail below
.
New Capability Name of Sichuan New Green Pharmaceutical Technology Development Co.
, Ltd.
: Production Quality Traceability Capability of Traditional Chinese Medicine Formula Granules New Green Pharmaceutical is a company mainly engaged in the research and development, production and operation of traditional Chinese medicine prescription granules, covering Chinese herbal medicine decoction pieces, new Chinese herbal medicines, and the major health industry of Chinese medicine.
A large-scale comprehensive pharmaceutical and pharmaceutical company that insists on relying on the construction of Chinese medicinal materials base, intensive processing as the core, scientific and technological innovation as the driving force, market expansion as the starting point, and promotion of Chinese medicine culture as its own responsibility, and strives to create a unique whole industry chain of traditional Chinese medicine formula particles.
Quality control system
.
Jiangsu Shuoshi Biotechnology Co.
, Ltd.
New Capability Name: Diagnostic Reagents/Instrument Marketing Control Capability In the field of in vitro testing services, an integrated business model of "instruments + reagents + services" has been realized
.
The company has a modern biological technology platform and currently has more than 500 products, which are widely used in infectious disease prevention and control, clinical testing, large-scale population screening, and prenatal and postnatal care management
.
Zhuzhou Qianjin Pharmaceutical Co.
, Ltd.
New Capability Name: Precision Marketing Capability of Chinese Patent Medicine Zhuzhou Qianjin Pharmaceutical Co.
, Ltd.
is mainly engaged in the development, production and sales of Chinese patent medicines, chemical medicines and feminine hygiene products, as well as the wholesale and retail business of medicines
.
The company has 12 kinds of preparations including tablets, capsules, granules, pills, decoctions, powders and solutions, 22 automated production lines, 115 drug registration approval documents and 18 API registration approval documents
.
The company’s leading products of proprietary Chinese medicines, Fuke Qianjin Tablets (capsules) and Buxue Yimu Pills (granules) are exclusive national-based medicines and National Medical Insurance Class A varieties.
Fuke Qianjin Capsules and Gynecological Duanhongyin Capsules are national Chinese medicine protected varieties
.
At present, the company has initially established a business structure for the entire pharmaceutical industry chain including pharmaceutical manufacturing, pharmaceutical circulation and Chinese medicine cultivation
.
Guangzhou Baiyunshan Zhongyi Pharmaceutical Co.
, Ltd.
new capability name: Chinese patent medicine full-process digital lean production control ability The top-level design of the tire pill has formed a spirit of perseverance and innovation, and has initially formed a more distinctive "Baiyunshan Zhongyi Experience" of keeping integrity and innovation in traditional Chinese medicine
.
As a manufacturer of Zishen Yutai Pills, Baiyunshan Zhongyi Pharmaceutical Co.
, Ltd.
has carried out more than 5000 clinical evidence-based medical research and toxicological research based on the characteristics of Zishen Yutai Pills for invigorating the kidney and assisting pregnancy and antifetus through modern research technology.
, Drug-effective material basic research and quality standard research, carry out assisted reproductive evidence-based medicine research, and help improve the technical system of diagnosis and treatment of integrated traditional Chinese and Western medicine for kidney tonifying, pregnancy and fetus prevention
.
Broad Pharmaceuticals (China) Co.
, Ltd.
New Capability Name: Group Financial Fine Control Capability Broad Pharmaceuticals adheres to the internationalization and scientific and technological innovation vision to continuously expand and implement new performance growth points, and gradually formed the "cardiovascular and cerebrovascular precision intervention diagnosis and treatment", "Two bombs and one star" innovative strategy of "anti-tumor" and "anti-virus and anti-infection"
.
At present, Yuanda Pharmaceutical has achieved a full product layout in five strategic markets in the field of cardio-cerebral vascular precision interventional diagnosis and treatment, and its product pipeline covers 9 global innovative medical devices. .
New capability name of Guilin Unitech Medical Electronics Co.
, Ltd.
: Refined production control capabilities based on the enterprise MES platform Unitech Group is a manufacturer, supplier and service provider of medical diagnostic products in China, and a national CAD (computer-aided design) application engineering demonstration Enterprise, the group has a modern medical equipment production base of 60,000 square meters, a number of imported advanced automated equipment, reagent production lines, is a Chinese medical equipment research and development manufacturing enterprise
.
Today, the company has a blood cell analysis system, a urine analysis system, a biochemical analysis system, an overall solution for primary medical informationization, point-of-care (POCT) diagnostic products, home medical diagnostic products, immunodiagnosis and genetic diagnosis systems, and general medical diagnosis systems And medical electronic products (monitor) and other products
.